Home » Psychology news » The FDA approve esketamine nasal spray for severe depression

The FDA approve esketamine nasal spray for severe depression

March 8, 2019 by

Federal regulators have approved the use of the new prescription nasal spray drug esketamine for depression that has not responded to other treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>